These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 29326542)

  • 1. Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.
    Guo W; Fumagalli L; Prior R; Van Den Bosch L
    Front Neurosci; 2017; 11():671. PubMed ID: 29326542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: Induced pluripotent stem cell models of frontotemporal dementia.
    Preza E; Hardy J; Warner T; Wray S
    Neuropathol Appl Neurobiol; 2016 Oct; 42(6):497-520. PubMed ID: 27291591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammation in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia and the Interest of Induced Pluripotent Stem Cells to Study Immune Cells Interactions With Neurons.
    Liu E; Karpf L; Bohl D
    Front Mol Neurosci; 2021; 14():767041. PubMed ID: 34970118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New In Vitro Models to Study Amyotrophic Lateral Sclerosis.
    Myszczynska M; Ferraiuolo L
    Brain Pathol; 2016 Mar; 26(2):258-65. PubMed ID: 26780562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From
    Anoar S; Woodling NS; Niccoli T
    Front Neurosci; 2021; 15():786076. PubMed ID: 34899176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.
    Giacomelli E; Vahsen BF; Calder EL; Xu Y; Scaber J; Gray E; Dafinca R; Talbot K; Studer L
    Cell Stem Cell; 2022 Jan; 29(1):11-35. PubMed ID: 34995492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Stem Cells to Model Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: From Basic Research to Regenerative Medicine.
    Hedges EC; Mehler VJ; Nishimura AL
    Stem Cells Int; 2016; 2016():9279516. PubMed ID: 26966440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Representing Diversity in the Dish: Using Patient-Derived
    Ghaffari LT; Starr A; Nelson AT; Sattler R
    Front Neurosci; 2018; 12():56. PubMed ID: 29479303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Derived iPSCs and iNs-Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases.
    Tang BL
    Cells; 2018 May; 7(5):. PubMed ID: 29738460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis.
    Du H; Huo Z; Chen Y; Zhao Z; Meng F; Wang X; Liu S; Zhang H; Zhou F; Liu J; Zhang L; Zhou S; Guan Y; Wang X
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease.
    Jaiswal MK
    Neural Regen Res; 2017 May; 12(5):723-736. PubMed ID: 28616022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
    Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
    Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology.
    Kühn R; Mahajan A; Canoll P; Hargus G
    Front Cell Dev Biol; 2021; 9():766773. PubMed ID: 34858989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
    Ji AL; Zhang X; Chen WW; Huang WJ
    J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs.
    Hawrot J; Imhof S; Wainger BJ
    Neurobiol Dis; 2020 Feb; 134():104680. PubMed ID: 31759135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.